Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core

NIH RePORTER · NIH · N01 · $11,116,941 · view on reporter.nih.gov ↗

Abstract

To provide expertise and state-of-the-art approaches to manufacture, formulate, optimize, and evaluate the safety and toxicity of innovative, cutting-edge influenza vaccine platforms and approaches.

Key facts

NIH application ID: 11057541
Project number: 75N93019C00053-P00024-9999-1
Recipient: DUKE UNIVERSITY
Principal Investigator: THOMAS DENNY
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $11,116,941
Award type: —
Project period: 2019-08-26 → 2028-03-13